We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more Volume 75 Issue 1 | Pathogens and Disease | Oxford Academic Skip to Main Content
Issue Cover
Volume 75, Issue 1
January 2017
EISSN 2049-632X
Issue navigation

Research Articles

Surprisingly, thickness, density and biomass of biofilms formed by non-typeable Haemophilus influenzae were not significantly correlated with resistance properties.

This manuscript describes identification of the first regulatory small RNAs that control the virulence of enteropathogenic Escherichia coli.

Simkania negevensis, an emerging Chlamydia-related bacterium, efficiently grows in human cells, suggesting a potential implication in human diseases, and harbors growth characteristics that differ from other known Chlamydiales.

Saccharomyces boulardii can protect against Helicobacter suis infection.

Effect of in vivo neutralization of tumor necrosis factor alpha on the efficacy of antibiotic treatment in systemic Salmonella enterica infections.

The study aimed to identify unique Mtb secreted proteins from the extensively drug resistant Mtb F15/LAM4/KZN phage secretome library. Based on phage DNA sequencing bioinformatics tools and databases, ten proteins essential for in vivo growth and survival of Mtb (Nrp, PssA, MmpL5, SirA, GatB, EspA, TopA, EccCa1, 38 Rv1634 and Rv3103c) were identified.

Cholesterol metabolism is affected during the acute phase of Chlamydia pneumoniae infection in mice which supports the involvement of this common respiratory bacterium in the development of atherosclerosis.

Dysregulated MMPs and TIMPs expression promoted endometrial extracellular matrix degradation and affected early pregnancy eventually leading to spontaneous abortion in Chlamydia trachomatis-infected recurrent aborters.

Short Communication

The results provide new information on the immunopathology of acute human hantavirus infections, indicating that indoleamine 2,3-dioxygenase mediates clinically significant immune suppression through regulatory T cells.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Subscribe Now